Skip to main content
. 2016 Jun 23;5(8):1873–1882. doi: 10.1002/cam4.780

Figure 2.

Figure 2

Relapse‐free survival (RFS) curve stratified by CHIP expression. (A) The survival of the high CHIP (score 3) group was slightly better than that of the low CHIP (scores 0, 1, or 2) group (P = 0.091). (B) In postmenopausal patients, RFS was significantly better in the high CHIP group than in the low CHIP group (P < 0.05). (C) RFS was significantly better in the estrogen receptor(ER)‐positive/CHIP‐score 3 group than in the ER‐negative/CHIP‐score 0 group (P < 0.05). (D) In postmenopausal patients, RFS was significantly better in the ER‐positive/CHIP‐score 3 group than in the ER‐negative/CHIP‐score 0 group (P < 0.05).